The Latest Breaking News from PBMs

TRICARE becomes part of fight over pharmacy benefit managers - Roll Call

Lawmakers question whether the decision to renew Express Scripts as TRICARE's pharmacy benefit manager is a wise decision.

Roll Call · Aug 13, 2024

Biden's plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say

Biden is campaigning on cutting drug costs for Medicare patients, but independent pharmacists say one strategy makes it unaffordable to keep some brand-name medicines in stock.

Fortune · Jun 11, 2024

Rural pharmacies fill a health care gap in the US. Owners say it's getting harder to stay open

Rural pharmacies can be a touchstone for their communities

The Independent UK · Jun 4, 2024

Howard Dean: 'At last, Congress proposes drug pricing reform that works'

The Patients Before Middlemen Act strikes at the heart of what makes prescription drugs so unaffordable in the U.S., according to Howard Dean.

Fortune · Sep 19, 2023

What you need to know about the drug price fight in those TV ads

In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it’s not always clear who’s sponsoring the ads or why.

Tribune News Service · Jul 18, 2023

What to know about the drug price fight in those TV ads

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

WEKU · Jul 7, 2023

Will lower-cost Humira pharmaceutical options soon be available to patients?

Seven new alternatives to the high-cost Humira drug will be available in July. Some will be offered at significantly lower prices, but will patients see big savings?

Tribune News Service · Jun 30, 2023

Humira, the world’s top-selling drug, faces an upcoming test from low cost alternatives

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor.

Tribune News Service · Jun 30, 2023

A more aggressive FTC is starting to target drug mergers and industry middlemen

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.

Tribune News Service · May 24, 2023

House, Senate craft separate health care packages - Roll Call

A deal announced this week on a series of drug pricing bills could be a sign of progress an issue that has bedeviled both parties.

Roll Call · Apr 27, 2023